天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 315180-17-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 315180-17-7
Chemical Structure| 315180-17-7
Structure of 315180-17-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 315180-17-7 ]

Related Doc. of [ 315180-17-7 ]

Alternatived Products of [ 315180-17-7 ]
Product Citations

Product Details of [ 315180-17-7 ]

CAS No. :315180-17-7 MDL No. :MFCD07783827
Formula : C6H6FNO Boiling Point : -
Linear Structure Formula :- InChI Key :OWTCZNAMUJIMOC-UHFFFAOYSA-N
M.W : 127.12 Pubchem ID :12045263
Synonyms :

Calculated chemistry of [ 315180-17-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 30.32
TPSA : 33.12 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -10.56 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.26
Log Po/w (XLOGP3) : -4.91
Log Po/w (WLOGP) : 0.98
Log Po/w (MLOGP) : 0.31
Log Po/w (SILICOS-IT) : 1.63
Consensus Log Po/w : -0.15

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : 2.04
Solubility : 13900.0 mg/ml ; 109.0 mol/l
Class : Highly soluble
Log S (Ali) : 4.85
Solubility : 8970000.0 mg/ml ; 70500.0 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -2.09
Solubility : 1.03 mg/ml ; 0.00807 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.54

Safety of [ 315180-17-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 315180-17-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 315180-17-7 ]

[ 315180-17-7 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 34798-95-3 ]
  • [ 315180-17-7 ]
  • 6-(6-fluoro-pyridin-2-ylmethoxy)-9<i>H</i>-purin-2-ylamine [ No CAS ]
  • 2
  • [ 315180-17-7 ]
  • 1-(2-amino-9H-purin-6-yl)-4-(dimethylamino)pyridin-1-ium chloride [ No CAS ]
  • 6-(6-fluoro-pyridin-2-ylmethoxy)-9<i>H</i>-purin-2-ylamine [ No CAS ]
  • 3
  • C9H8FNO4 [ No CAS ]
  • [ 315180-17-7 ]
  • 4
  • [ 315180-16-6 ]
  • [ 315180-17-7 ]
  • 5
  • [ 402-69-7 ]
  • [ 315180-17-7 ]
  • 6
  • [ 407-22-7 ]
  • [ 315180-17-7 ]
  • 8
  • [ 315180-17-7 ]
  • [ 315180-16-6 ]
YieldReaction ConditionsOperation in experiment
With thionyl chloride; In dichloromethane; at 20℃; for 2h; Production Example 7-3: 2-Chloromethyl-6-fluoropyridine: Thionyl chloride (25 mL) was added to a dichloromethane solution (80 mL) of the compound (1.1 g) obtained in Production Example 7-2, and stirred at room temperature for 2 hours. The solvent was evaporated off under reduced pressure, ethyl acetate was added to the resulting residue, and the organic layer was washed with aqueous saturated sodium hydrogencarbonate solution. The organic layer was dried with anhydrous magnesium sulfate, and the solvent was evaporated off under reduced pressure to obtain the entitled compound (990 mg).
  • 9
  • 2-chloro-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoline [ No CAS ]
  • [ 315180-17-7 ]
  • 2-[(6-fluoropyridin-2-yl)methoxy]-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoline [ No CAS ]
YieldReaction ConditionsOperation in experiment
26 mg With 4,5-bis-(di-tert-butyl-phosphanyl)-9,9-dimethyl-9H-xanthene; tris(dibenzylideneacetone)dipalladium(0) chloroform complex; caesium carbonate; In toluene; at 100℃; for 4h;Inert atmosphere; Example 86 2-[(6-Fluoropyridin-2-yl)methoxy]-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoline To 2-chloro-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoli ne (65 mg), <strong>[315180-17-7](6-fluoropyridin-2-yl)methanol</strong> (34 mg), Pd2(dba)3·CHCl3 (17 mg), t-Bu-X-Phos (18 mg) and cesium carbonate (174 mg) was added toluene (2.6 mL), and the mixture was degassed, then stirred at 100C for 4 hours under Ar atmosphere. The mixture was filtered through Celite and the solvent was evaporated under reduced pressure. The resulting residue was purified by silica gel column chromatography to give the title compound (26 mg) as colorless oil. [MS (ESI) m/z 336.2 (M+H)+]
  • 10
  • 2-chloro-4-(pyrimidin-5-yl)-5,6,7,8-tetrahydroquinoline [ No CAS ]
  • [ 315180-17-7 ]
  • 2-[(6-fluoropyridin-2-yl)methoxy]-4-(pyrimidin-5-yl)-5,6,7,8-tetrahydroquinoline [ No CAS ]
YieldReaction ConditionsOperation in experiment
59 mg With 4,5-bis-(di-tert-butyl-phosphanyl)-9,9-dimethyl-9H-xanthene; tris(dibenzylideneacetone)dipalladium(0) chloroform complex; caesium carbonate; In toluene; at 100℃; for 14h;Inert atmosphere; [Step 2] Production of 2-[(6-fluoropyridin-2-yl)methoxy]-4-(pyrimidin-5-yl )-5,6,7,8-tetrahydroquinoline To 2-chloro-4-(pyrimidin-5-yl)-5,6,7,8-tetrahydroquino line (71 mg), <strong>[315180-17-7](6-fluoropyridin-2-yl)methanol</strong> (41 mg), Pd2(dba)3·CHCl3 (20 mg), t-Bu-X-Phos (33 mg) and cesium carbonate (315 mg) was added toluene (2.9 mL), and the mixture was degassed, then stirred under Ar atmosphere at 100C for 14 hours. After the reaction mixture was allowed to return to room temperature, diluted with ethyl acetate, filtered through Celite, and the filtrate was evaporated under reduced pressure. The resulting residue was purified by silica gel column chromatography to give the title compound (59 mg) as a pale yellow powder. [MS (ESI) m/z 337.3 (M+H)+]
  • 11
  • 2-chloro-4-(pyrimidin-5-yl)-5,6,7,8-tetrahydroquinoline [ No CAS ]
  • [ 315180-17-7 ]
  • 6-([4-(pyrimidin-5-yl)-5,6,7,8-tetrahydroquinolin-2-yl]oxy}methyl)pyridin-2-amine [ No CAS ]
  • 12
  • 2-chloro-4-(2-methylpyrimidin-5-yl)-6,7-dihydro-5H-cyclopenta[b]pyridine [ No CAS ]
  • [ 315180-17-7 ]
  • 2-[(6-fluoropyridin-2-yl)methoxy]-4-(2-methylpyrimidin-5-yl)-6,7-dihydro-5H-cyclopenta[b]pyridine [ No CAS ]
YieldReaction ConditionsOperation in experiment
22 mg With 4,5-bis-(di-tert-butyl-phosphanyl)-9,9-dimethyl-9H-xanthene; tris(dibenzylideneacetone)dipalladium(0) chloroform complex; sodium t-butanolate; In toluene; at 100℃; for 4h;Molecular sieve; Inert atmosphere; Example 39 2-[(6-Fluoropyridin-2-yl)methoxy]-4-(2-methylpyrimi din-5-yl)-6,7-dihydro-5H-cyclopenta[b]pyridine To 2-chloro-4-(2-methylpyrimidin-5-yl)-6,7-dihydro-5H-cyclopenta[b]pyridine (100 mg), <strong>[315180-17-7](6-fluoropyridin-2-yl)methanol</strong> (62 mg), t-Bu-X-Phos (41 mg), NaO-t-Bu (78 mg), Pd2(dba)3·CHCl3 (25 mg) and MS4A was added toluene (2 mL), and the mixture was degassed, then stirred under Ar atmosphere at 100C for 4 hours. After the reaction mixture was allowed to return to room temperature, diluted with ethyl acetate, filtered through Celite, and the filtrate was evaporated under reduced pressure. The resulting residue was purified by silica gel column chromatography to give the title compound (22 mg) as a white powder. [MS (ESI) m/z 337.4 (M+H)+]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;